The latest announcement is out from Monogram Orthopaedics Inc ( (MGRM) ).
Monogram Technologies, an AI-driven robotics company, reported significant progress in the third quarter of 2024, including a $13 million public offering to fund commercialization milestones. They submitted a 510(k) premarket filing to the FDA for their mBôs TKA System and secured a collaboration with Shalby Limited for clinical trials in India. Despite a net loss of $5 million, the company focuses on gaining FDA clearance and expanding international relationships. Monogram was named ‘Orthopedic Joint Replacement Company of the Year 2024’ by Medical Tech Outlook.
Learn more about MGRM stock on TipRanks’ Stock Analysis page.
